Breast Cancer Risk Assessment in 64,659 Women at a Single High-Volume Mammography Clinic

Academic Radiology

Volumn 19, Issue 1, 2012, Pages 95-99

  Brinton, John T ^a   Barke, Lora D ^b   Freivogel, Mary E ^b   Jackson, Stacy ^b   O'Donnell, Colin I ^a   Glueck, Deborah H ^a  

^a Global Health and Health Disparities   (United States)

^b INVISION SALLY JOBE   (United States)

Author keywords

Breast cancer; Clinical effectiveness; Risk assessment

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST MAGNETIC RESONANCE IMAGING; CANCER RISK; CANCER SCREENING; CLINICAL PRACTICE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; DEVICE; DIGITAL MAMMOGRAPHY; FAMILY HISTORY; FEMALE; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COLORADO; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 82955247871     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.09.003     Document Type: Article

References (19)

1. United States Cancer Statistics: 1999-2006 Incidence and Mortality Web-based Report 2010, US Cancer Statistics Working Group, US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, GA, Available at:, Accessed May 10, 2010. http://www.cdc.gov/uscs.
2. Esserman L., Shieh Y., Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009, 302:1685-1692.
3. Nelson H.D., Tyne K., Naik A., et al. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med 2009, 151:727-737. US Preventive Services Task Force, W237-W242. Review.
4. Hendrick R.E., Smith R.A., Rutledge J.H., et al. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997, 22:87-92.
5. Kerlikowske K., Grady D., Rubin S.M., et al. Efficacy of screening mammography. A meta-analysis. JAMA 1995, 273:149-154.
6. National Center for Health Statistics. Health, United States, 2009: With Special Feature on Medical Technology. Hyattsville, MD. 2010. Library of Congress Catalog Number 76-641496. For sale by Superintendent of Documents U.S. Government Printing Office Washington, DC 20402.
7. Pisano E.D., Gatsonis C., Hendrick E., et al. Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005, 353:1773-1783. Erratum in: N Engl J Med 2006; 355:1840.
8. Bluemke D.A., Gatsonis C.A., Chen M.H., et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004, 292:2735-2742.
9. Saslow D., Boetes C., Burke W., et al. American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57:75-89. Erratum in: CA Cancer J Clin 2007; 57:185.
10. Gail M.H., Brinton L.A., Byar D.P., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81:1879-1886.
11. Gail M.H., Costantino J.P., Pee D., et al. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 2007, 99:1782-1792.
12. D'Orsi C.J., Bassett L.W., Berg W.A., et al. Breast Imaging Reporting and Data System, BI-RADS: Mammography 2003, American College of Radiology, Reston, VA. 4th ed.
13. US National Institutes of Health, National Cancer Institute, Breast Cancer Risk assessment tool. Bethesda, MD: US National Institutes of Health. Risk calculator. Available from: Accessed June 10, 2010. http://www.cancer.gov/bcrisktool/Default.aspx.
14. Yates F. Test of significance for 2 x 2 contingency tables. J Royal Stat Soc Series A (General) 1984, 147:426-463.
15. Murphy C.D., Lee J.M., Drohan B., et al. The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing. Cancer 2008, 113:3116-3320.
16. Berry D.A., Parmigiani G., Sanchez J., et al. Probability of carrying amutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 1997, 89:227-238.
17. Parmigiani G., Berry D., Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998, 62:145-158.
18. Berg W.A., Blume J.D., Adams A.M., et al. Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology 2010, 254:79-87.
19. Tyrer J., Duffy S.W., Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004, 23:1111-1130.